GUFICBIO
Invest Now

Gufic BioSciences Share Price
₹336.30 +4.7 (1.42%)
29 Mar, 2025 05:03
Start SIP in
GUFICBIO
Performance
- Low
- ₹333
- High
- ₹341
- 52 Week Low
- ₹278
- 52 Week High
- ₹504
- Open Price₹333
- Previous Close₹332
- Volume28,547
Investment Returns
- Over 1 Month + 0.25%
- Over 3 Month -24.37%
- Over 6 Month -11.59%
- Over 1 Year + 17.88%
Smart Investing Starts Here Start SIP with Gufic BioSciences for Steady Growth!
Gufic BioSciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41.1
- PEG Ratio
- 1.7
- Market Cap Cr
- 3,372
- P/B Ratio
- 5.9
- Average True Range
- 16.95
- EPS
- 8.17
- Dividend Yield
- 0
- MACD Signal
- -15.29
- RSI
- 40.21
- MFI
- 48.47
Gufic BioSciences Financials
Gufic BioSciences Technicals
EMA & SMA
Current Price
₹336.30
+
4.7
(1.42%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹348.04
- 50 Day
- ₹375.39
- 100 Day
- ₹392.94
- 200 Day
- ₹387.41
Resistance and Support
336.67
- R3 348.63
- R2 344.77
- R1 340.53
- S1 332.43
- S2 328.57
- S3 324.33
Gufic BioSciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results & Others | To consider other business matters. per share(5%)Final Dividend |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-29 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results |
Gufic BioSciences F&O
About Gufic BioSciences
- NSE Symbol
- GUFICBIO
- BSE Symbol
- 509079
- Chairman & Managing Director
- Mr. Jayesh P Choksi
- ISIN
- INE742B01025
Similar Stocks to Gufic BioSciences
Gufic BioSciences FAQs
Gufic BioSciences share price is ₹336 As on 29 March, 2025 | 04:49
The Market Cap of Gufic BioSciences is ₹3372.3 Cr As on 29 March, 2025 | 04:49
The P/E ratio of Gufic BioSciences is 41.1 As on 29 March, 2025 | 04:49
The PB ratio of Gufic BioSciences is 5.9 As on 29 March, 2025 | 04:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.